Dataset Information

DEcancer: Machine learning framework tailored to liquid biopsy based cancer detection and biomarker signature selection.

ABSTRACT: Cancer is a leading cause of mortality worldwide. Over 50% of cancers are diagnosed late, rendering many treatments ineffective. Existing liquid biopsy studies demonstrate a minimally invasive and inexpensive approach for disease detection but lack parsimonious biomarker selection, exhibit poor cancer detection performance and lack appropriate validation and testing. We established a tailored machine learning pipeline, DEcancer, for liquid biopsy analysis that addresses these limitations and improved performance. In a test set from a published cohort of 1,005 patients including 8 cancer types and 812 cancer-free individuals, DEcancer increased stage 1 cancer detection sensitivity across cancer types from 48 to 90%. In addition, with a test set cohort of patients from a high dimensional proteomics dataset of 61 lung cancer patients and 80 cancer-free individuals, DEcancer's performance using a 14-43 protein panel was comparable to 1,000 original proteins. DEcancer is a promising tool which may facilitate improved cancer detection and management.

SUBMITTER: Halner A

PROVIDER: S-EPMC10165183 | biostudies-literature | 2023 May

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

DEcancer: Machine learning framework tailored to liquid biopsy based cancer detection and biomarker signature selection.

Halner Andreas A Hankey Luke L Liang Zhu Z Pozzetti Francesco F Szulc Daniel D Mi Ella E Liu Geoffrey G Kessler Benedikt M BM Syed Junetha J Liu Peter Jianrui PJ

iScience 20230411 5

Cancer is a leading cause of mortality worldwide. Over 50% of cancers are diagnosed late, rendering many treatments ineffective. Existing liquid biopsy studies demonstrate a minimally invasive and inexpensive approach for disease detection but lack parsimonious biomarker selection, exhibit poor cancer detection performance and lack appropriate validation and testing. We established a tailored machine learning pipeline, DEcancer, for liquid biopsy analysis that addresses these limitations and imp ...[more]

PMID: 37168566

Similar Datasets

Project description:Autism spectrum disorder is the most used umbrella term for a myriad of neuro-degenerative/developmental conditions typified by inappropriate social behavior, lack of communication/comprehension skills, and restricted mental and emotional maturity. The intriguing factor of this disorder is attributed to the fact that it can be detected only by close monitoring of developmental milestones after childbirth. Moreover, the exact causes for the occurrence of this neurodevelopmental condition are still unknown. Besides, autism is prevalent across individuals irrespective of ethnicity, genetic/familial history, and economic/educational background. Although research suggests that autism is genetic in nature and early detection of this disorder can greatly enhance the independent lifestyle and societal adaptability of affected individuals, there is still a great dearth of information to support the statement of proven facts and figures. This research work places emphasis on the application of automated machine learning incorporated with feature ranking techniques to generate significant feature signatures for the early detection of autism. Publicly available datasets based on the Q-chat scores of individuals across diverse age groups-toddlers, children, adolescents, and adults have been employed in this study. A machine learning framework based on automated hyperparameter optimization is proposed in this work to rank the potential nonclinical markers for autism. Moreover, this study aimed at ranking the AutoML models based on Mathew's correlation coefficient and balanced accuracy via which nonclinical markers were identified from these datasets. Besides, the feature signatures and their significance in distinguishing between classes are being reported for the first time in autism detection. The proposed framework yielded ∼90% MCC and ∼95% balanced accuracy across all four age groups of autism datasets. Deep learning approaches have yielded a maximum of 92.7% accuracy on the same datasets but are limited in their ability to extract significant markers, have not reported on MCC for unbalanced data, and cannot adapt automatically to new data entries. However, AutoML approaches are more flexible, easier to implement, and provide automated optimization, thereby yielding the highest accuracy with minimal user intervention.

Project description:In the recent JAVELIN Bladder 100 phase 3 trial, avelumab plus best supportive care significantly prolonged overall survival relative to best supportive care alone as first-line maintenance therapy following first-line platinum-based chemotherapy in patients with advanced urothelial cancer (aUC). Discovering biomarkers using genomic profiling to understand potential patient heterogeneity is essential to help improve patient care with precision medicine. For the JAVELIN Bladder 100 trial, it is unclear which variable selection methods can most reliably identify biomarkers to inform patient care because the dataset is characterized by high collinearity and low signal. The aim of this paper was to evaluate available selection methods and their ability to discover prognostic and predictive biomarkers in patients with aUC receiving first-line maintenance therapy. A simulation study evaluated the performance of popular variable selection approaches for high-dimensional data, including penalized regression models, random survival forests, and Bayesian variable selection methods. For Bayesian variable selection methods, a modified Bayesian Information Criterion (BIC) thresholding rule was proposed in addition to the traditional BIC thresholding rule. These methods were applied to the JAVELIN Bladder 100 dataset to investigate potential biomarkers associated with survival benefit. Results from the simulations demonstrated the strengths and limitations of the different methods. The variable selection methods demonstrated low false discovery rates under different conditions. However, their performance declined in the presence of high collinearity. Using the JAVELIN Bladder 100 data, we identified some potentially significant biomarkers across multiple models. Several lasso-related methods were able to identify potentially biologically meaningful variables in the trial. Some variable selection methods (such as stochastic search variable selection and random survival forest) may not be well suited to this type of data due to the presence of extreme collinearity and low signal. Future research should explore novel variable selection methods that may be more suitable for identifying prognostic and predictive biomarkers in this population.Trial registration: ClinicalTrials.gov Identifier: NCT02603432.

Project description:The challenge of developing an Android malware detection framework that can identify malware in real-world apps is difficult for academicians and researchers. The vulnerability lies in the permission model of Android. Therefore, it has attracted the attention of various researchers to develop an Android malware detection model using permission or a set of permissions. Academicians and researchers have used all extracted features in previous studies, resulting in overburdening while creating malware detection models. But, the effectiveness of the machine learning model depends on the relevant features, which help in reducing the value of misclassification errors and have excellent discriminative power. A feature selection framework is proposed in this research paper that helps in selecting the relevant features. In the first stage of the proposed framework, t-test, and univariate logistic regression are implemented on our collected feature data set to classify their capacity for detecting malware. Multivariate linear regression stepwise forward selection and correlation analysis are implemented in the second stage to evaluate the correctness of the features selected in the first stage. Furthermore, the resulting features are used as input in the development of malware detection models using three ensemble methods and a neural network with six different machine-learning algorithms. The developed models' performance is compared using two performance parameters: F-measure and Accuracy. The experiment is performed by using half a million different Android apps. The empirical findings reveal that malware detection model developed using features selected by implementing proposed feature selection framework achieved higher detection rate as compared to the model developed using all extracted features data set. Further, when compared to previously developed frameworks or methodologies, the experimental results indicates that model developed in this study achieved an accuracy of 98.8%.

Dataset Information

DEcancer: Machine learning framework tailored to liquid biopsy based cancer detection and biomarker signature selection.

Publications

DEcancer: Machine learning framework tailored to liquid biopsy based cancer detection and biomarker signature selection.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets